Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality around the world. An estimated 6 million healthcare-associated infections occur each year across the U.S., Europe and Japan alone. In the U.S. up to 90,000 patients die as a result of healthcare-associated infections each year, making healthcare-associated infections the fourth leading cause of death. Beyond the human toll, there is an enormous financial burden to healthcare systems worldwide. BD is committed to applying its expertise, resources and technologies toward the prevention of healthcare-associated infections worldwide. If you are a member of the media and have questions about these materials, please contact Barbara Kalavik, Director, WW Public Relations at barbara_kalavik@bd.com.

Backgrounders
News Releases
Events
Multimedia Resources
Additional Resources

Backgrounders

  Healthcare-Associated Infections At A Glance
  Methicillin-resistant Staphylococcus aureus At A Glance
  Active Surveillance At A Glance
  BD GeneOhm™ MRSA Assay At A Glance
  Benefits of Rapid Testing
  Key Research Papers Relevant to the BD GeneOhm™ MRSA Assay
  Emergence of MRSA Timeline
  HAI Terminology Guide

Return to top

News Releases

• BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance (May 1, 2008)
  
  
• Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU (April 7, 2008)
  
  
• BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates (March 17, 2008)
  
  
• BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures (January 2, 2008)
  
  
• BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens (December 20, 2007)
  
  
• UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 percent (December 18, 2007)
  
  
• BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures (May 21, 2007)
  
  
• BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures (April 25, 2007)
  
  
• BD Helping APIC to Expand its Mission in HAIs Prevention at the APIC Futures Summit (January 27, 2007)
  
  
• "Grand Rounds" Address Impact of Antibiotic-Resistant Superbug on Healthcare Facilities (November 16, 2006)
  
  
• Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (November 6, 2006)
  
  
• Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (November 5, 2006)
  
  
• BD Completes Acquisition of GeneOhm Sciences, Inc. (February 14, 2006)
  
  

Events

Upcoming Events 

Return to top

Multimedia Resources

BD on TV (Videos)
   - CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (October 22, 2007)

Return to top

Additional Resources

Visit our Healthcare-Associated Infections Site
Permission Request Form (to use BD logo or for reprint and distribution of BD materials)

Return to top